17 Capital Partners’s Fidelity Blue Chip Growth ETF FBCG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Buy
24,705
+2,346
+10% +$125K 0.64% 41
2025
Q4
$1.23M Buy
22,359
+6,575
+42% +$357K 0.63% 49
2025
Q3
$847K Buy
15,784
+1,751
+12% +$89.2K 0.46% 79
2025
Q2
$677K Buy
14,033
+2,487
+22% +$106K 0.39% 86
2025
Q1
$461K Buy
11,546
+526
+5% +$23.8K 0.3% 103
2024
Q4
$510K Buy
11,020
+913
+9% +$41.4K 0.32% 92
2024
Q3
$432K Buy
10,107
+2,295
+29% +$94.9K 0.28% 97
2024
Q2
$332K Buy
7,812
+1,868
+31% +$73.8K 0.24% 104
2024
Q1
$229K Buy
+5,944
New +$214K 0.17% 115

Other funds holding FBCG

17 Capital Partners's FBCG Position: Q1 2026 in Review

17 Capital Partners increased its Fidelity Blue Chip Growth ETF (FBCG) stake by 10% in Q1 2026, buying an estimated $125K and bringing the position to 24,705 shares worth $1.24M. The position accounts for 0.64% of the portfolio, ranked #41.

17 Capital Partners first reported a position in FBCG in Q1 2024 and has held it in 9 quarters since. 266 funds tracked by Wall St. Rank hold FBCG as of Q1 2026.

  • 17 Capital Partners held 24,705 shares of Fidelity Blue Chip Growth ETF worth $1.24M as of Q1 2026.
  • 17 Capital Partners bought 2,346 Fidelity Blue Chip Growth ETF shares in Q1 2026, an estimated $125K.
  • Fidelity Blue Chip Growth ETF made up 0.64% of 17 Capital Partners's portfolio in Q1 2026, its #41 holding.
  • 17 Capital Partners first reported a position in Fidelity Blue Chip Growth ETF in Q1 2024 and has held it in 9 quarters since.
  • 266 funds tracked by Wall St. Rank held Fidelity Blue Chip Growth ETF as of Q1 2026.

Based on 17 Capital Partners's 13F filing for Q1 2026, filed 13 May 2026.